Millions of people worldwide are affected by Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Yet the causes, diagnostic markers, progression, and FDA-approved treatments remain unknown. The shared vision of the ME/CFS Collaborative Research Network (ME/CFSnet) is to encourage collaborative research in partnership with individuals and advocacy groups to understand the disease and develop better diagnosis and treatment.
Advances in Understanding the Pathophysiology of Chronic Fatigue Syndrome Cited Among Most Popular JAMA Articles for 2019
December 28, 2019
Dr. Anthony Komaroff's article about understanding the pathophysiology of ME/CFS, published in the Journal of the American Medical Association (JAMA), was the 6th most viewed article in the 2019 JAMA Network. As of January 3, the article had more than 77,000 views.Take Me There
These institutions are working together as the ME/CFS Research Network.
Visit the CDC to learn more about ME/CFS.
Investigators, health care providers, and advocates are collaborating across the Research Network to drive progress in understanding ME/CFS. Together, we can advance discoveries to improve the lives of members of the ME/CFS community.
Grants that fund ME/CFSnet are managed by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases and the National Institute of Neurological Disorders and Stroke.
What is ME/CFS?
Myalgic Encephalomyelitis (ME), also referred to as Chronic Fatigue Syndrome (CFS), is a multi-system disease that causes dysfunction of the neurological, immune, endocrine, and energy metabolism systems.